(Q40638371)

English

Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate

scientific article published on June 1999

Statements

Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate (English)
Sievers EL
Spielberger RT
Forman SJ
Flowers D
Smith FO
Shannon-Dorcy K
Berger MS
Bernstein ID
1 June 1999
3678-3684

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit